Latest Stock Market News

Sun Pharma Advanced Research Company (SPARC) is a clinical-stage bio-pharmaceutical company focused on continuously improving standards of care for patients globally, through innovation in therapeutics and delivery. SPARC was formed in 2007 following its demerger from Sun Pharma, a global leader in speciality generics.

“This Budget will see a continued push on capex and infrastructure. That will be a focus area in the Budget. There will be a continued focus on renewables and green energy. Hydrogen will be a focus area as well. Thus will be a continued growth Budget, very consistent with the messages that the government has given in the previous Budgets as well.”

Alibaba in November raised the size of its share repurchase program to $40 billion, increasing it by $15 billion, and said it would extend the time frame for the program through the end of March, 2025.

The brokerage has a BUY rating on HPCL on valuation grounds. OMCs are trading at attractive valuations. Optimism on OMCs will be contingent on crude sustaining below ~USD 80/bbl and the government giving them significant compensation for FY23 auto-fuel under recoveries.

As of 30-Sep-2022, promoters held 45.25 per cent stake in the company, while FIIs held 19.3 per cent and domestic institutional investors had 18.04 per cent.

Lane added that rates are now "ballpark" neutral where they are neither stimulating nor holding back growth and the peak will depend on how the economy responds to hikes that have already totalled 2.5 percentage points since July, the paper quoted him on Tuesday as saying.

A total of 5,147 shares changed hands on the counter till 12:35PM (IST)

Bharat Petroleum Corporation, incorporated in the year 1952, is a Large Cap company (having a market cap of Rs 75316.46 Crore) operating in Gas & Petroleum sector.

Higher base above upper band of falling channel with decline of CY22 provides favourable risk reward.

In the first Fed meeting of 2023, Powell is widely expected to slow down the pace of interest rate hikes. CME FedWatch Tool shows a 91% probability of a 25 basis point rate hike in the two-day Jan 31-Feb 1 meeting.